Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Mid-range Performer
914.6500 13.40 (1.49%)
NSE Dec 31, 2025 11:21 AM
Volume: 15,953
 

logo
Alivus Life Sciences Ltd.
27 Jan 2023
914.65
1.49%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Alivus Life Sciences Ltd. is trading above its 50 day SMA of 903.7
More from Alivus Life Sciences Ltd.
Recommended
Market trades higher, Shakti Pumps bags Rs 170 crore solar pump order
Trendlyne Marketwatch | 31 Dec 2025, 11:34AM
IPO activity is high on listings, but low on subscriptions
| 29 Dec 2025, 05:02PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021